Breast cancer drug tested before surgery in small study
NCT ID NCT03535506
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 23 times
Summary
This study looked at whether giving the drug palbociclib before surgery is possible for people with ductal carcinoma in situ (DCIS), a very early form of breast cancer. It planned to enroll 24 participants, with half receiving the drug and half not. The main goal was to see if enough people could complete the treatment. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DCIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Medstar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Conditions
Explore the condition pages connected to this study.